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In 2003, the revised American Cancer Society guidelines recommended that breast self-examination (BSE) be optional. Of 822
women diagnosed with breast cancer in our hospital from 1994 to 2004, sixty four (7.7%) were 40 years of age or younger.
Forty four (68.7%) of these young women discovered their breast cancers on BSE, 17 (18%) by mammography, and 3 (4.7%)
by clinical breast examination by medical professionals. Of 758 women over 40 years of age diagnosed with breast cancer, 382
(49%) discovered their cancer by mammography, 278 (39%) by BSE, and 98 (14%) by a clinical breast examination. Lymph node
metastases in the older women was one-half that in the younger women (21% versus 42%), and a higher percentage of younger
women presented with more advanced disease. In response to increasing breast cancer in young women under 41 years of age,
encouragement of proper breast self-examination is warranted and should be advocated.
1.Introduction
Our interest in undertaking this study was inﬂuenced by
the following disconcerting factors. Breast cancer is the
most common malignancy in females, accounting for 1 of
4 cancers diagnosed, and it is the second leading cause
of deaths due to cancer among North American women.
The American Cancer Society predicted that cancer of the
breast would be diagnosed in 254,650 women and that
40,170 women would die secondary to breast cancer in 2009
[1]. Moreover, the American Cancer Society estimated that
25,100 new breast cancers would be diagnosed, with 2,820
deaths secondary to breast cancer, occurring in American
women under 45 years of age in 2009 [1]. The incidence
of initial presentation of breast cancer is known to peak
between the ages of 45 and 55 years, and although women
40 years of age and under account for less than 5% of
those developing this disease, we observed that during the
last ten years, the incidence of breast cancer has increased
most markedly in this younger population. Changes in
diet, an escalating incidence of obesity, and an increased
exposure to endogenous and exogenous hormones may have
contributed to this increase, together with the decisions by
larger numbers of women in the developed world to delay
their ﬁrst pregnancy until later in life. Finally, the 5-year
survivalrateislowerforwomendiagnosedwithbreastcancer
before age 40 (83%) compared with women diagnosed at
ages 40 years or older (90%). These observations prompted
us to examine the diﬀerencesthat might exist between young
women 40 years of age and younger, and older women, with
breast cancer.
A fundamental diﬀerence in the pathophysiology is that
young women tend to present with a more advanced stage of
breast cancer than do older women, and, hence, the earliest
possible detection is crucial to their optimal prognosis. It is
important to emphasize that a malignant breast neoplasm
which has grown to a palpable size usually presents as a
painless mass [2].Many studieshaveshown that womenwho
regularly practice breast self-examination initially present
with smaller tumors and with neoplasms that less frequently
involve the axillary lymph nodes [3–10]. Despite these
facts, the American Cancer Society decided to change their
previous guideline forregular breast self-examination (BSE),
recommending instead that BSE now be optional because
beneﬁts of performing the self-examination had not been
substantiated unequivocally in the literature [11].2 International Journal of Surgical Oncology
The guidelines advocated by the American Cancer Soci-
ety in 2003 for early breast cancerdetectionin asymptomatic
women over 40 years of age were very speciﬁc: annual
mammography, annual clinical breast examination, and an
optionalmonthlybreast self-examination. The guidelinesare
less stringent for females under 40 years of age and consist
of a clinical breast examination every three years and an
optional monthly breast self-examination. Mammographic
screening in the patient population under 40 years of age
remains controversial. The American Cancer Society elimi-
nated its recommendation that all women perform monthly
BSE after publication of studies such as the randomized
trial of 266,062 women in Shanghai, which concluded that
intensive instruction in BSE does not reduce the mortality
rate of breast cancer [11]. Nonetheless, the society still
recommends that women be informed of the potential
beneﬁts and limitations of BSE and that those women who
wish to do so should receive instruction in proper BSE from
their health care providers [11].
We hypothesized that younger women are more con-
cerned with breast disease as it relates to their breast
image and appearance, to their lifestyle, and to longer life
expectancy. The various considerations and observations
concerning young women and their breast disease led us to
attempt to understand several concepts more clearly, includ-
ing the relationships between breast carcinoma biology and
age, breast carcinoma management patterns and age, and
outcomes and age.
The purpose of this study was to evaluate the character-
istics that are unique to women 40 years of age and under,
whopresent with breast cancer,inordertoassess theroleand
potential beneﬁts of BSE more meaningfully. Presumably,
diagnosis and treatment of breast lesions are delayed in
young women due to a low index of suspicion. Thus, we
evaluated the detection, incidence, and treatment patterns of
women 40 years of age and under with breast cancer who
presented to our community teaching hospital over a 10-
year period. The clinical and pathological characteristics of
cancer in this patient population and the role of BSE as a
screening tool in detecting malignancy in these patients were
also examined.
2.Materialsand Methods
Young women were deﬁned as those 40 years old or younger.
After approval by the Institutional Review Board, a retro-
spectivereviewofatotalof822womendiagnosedwithbreast
carcinoma during the decade between the years of 1994 and
2005 was completed at our community teaching hospital. Of
those, 64 women were below 41 years of age, accounting for
7.7%of all breast cancers.Retrospective clinicalinformation,
which was obtained from the tumor registry, the hospital
medical records, and oﬃce charts, was analyzed. In order
to create a uniform basis for comparison, the tumors of all
patients were restaged according to the TNM classiﬁcation
advocated by the American Joint Committee on Cancer
(AJCC). Tumor size and the status of the axillary nodes were
ascertained from review of the original pathology reports.
Mann Whitney, Fisher Exact, and Chi-Squared tests were
used as appropriate to compare the two age groups of breast
cancer patients, and P<. 05 was considered statistically
signiﬁcant. All of the 822 women with breast cancer were
treated in our institution, and none were referred elsewhere.
Surgical procedures were coded in accordance with the Data
Acquisition Manual (DAM). Breast-conserving surgery was
compared with mastectomy in both age groups.
3.Results
Throughout the decade-long study period, a statistically
signiﬁcant increaseinage-adjustedincidenceofbreastcancer
among women 40 years of age and younger became obvious
(P<. 005). The number of patients having a signiﬁcant
family history for breast cancer in both groups (>40 years
and <41 years) could not be derived accurately from the
family history data recorded on the charts, especially during
the 1990s. The entries for these data improved remarkably
in the 21st century but were suﬃciently inconsistent to be
of signiﬁcant value in this group of patients. Similarly, the
situation was comparable regarding genetic testing in these
patients during the time period of the study (1994–2005).
Of the 758 older patients, over the age of 40, three hundred
eighty two (49%) discovered their cancer by mammography,
278 (39%) by self-examination, and 98 (14%) by a clinical
breast examination. Magnetic resonance imaging (MRI)
was not available for use in the diagnosis of patients with
breast cancer during the decade of this study. Estrogen
and progesterone receptor status was known in 660 (80%)
patients and unknown in 166 (20%). Lymph nodes were
positive in 156 (21%) patients and unknown in 154 (21%)
of the older patients. At the time the older patients had
their breast cancers diagnosed, 122 (16%) patients had Stage
0 disease, 331 (44%) had Stage I, 212 (28%) had Stage II,
48 (6%) had Stage III, 21 (3%) had Stage IV, and 24 (3%)
had an indeterminate stage. Of 822 women diagnosed with
breast cancer in our hospital from 1994 to 2004, sixty four
(7.7%) were 40 years of age or younger. The ages of the 64
young patients ranged from 19 to 40 years, with a mean
age of 36.4 years. Forty four (69%) of these younger women
discoveredtheirbreast cancersby breast self-examination, 17
(18%)bymammography, and3(5%)byprofessional clinical
breast examination. This series spans 10 years, and the
surgical procedures chosen reﬂect the dominant inﬂuences
of that time period. Thirty three (50%) of these young
patients underwent a modiﬁed radical mastectomy, and 2
(3%) underwent a simple mastectomy. Only 28 (44%) of
the patients chose to have a breast conservation procedure.
The remaining three patients had no surgical treatment
recorded. Hormone receptors were positive in 41 (64%)
patients. Lymph nodes were positive for malignancy in 27
(42%) of patients sampled. There were 14 (22%) patients
withStage0,14(22%)patientswithStageIdisease,25(39%)
patientswith StageII, 9 (14%)with StageIII, 0 with StageIV,
and 2 (3%)young patients with an unknown stage. Sixof the
patients studied died of their disease. The number of young
patients diagnosed per year appeared to be increasing, evenInternational Journal of Surgical Oncology 3
Table 1: Data comparing younger and older breast cancer patients.
Total patient number (N)%N>40 years (old) % N<41 years (young) % P value
822 758 92 64 8
Method of discovery
Mammography 399 49 382 49 17 18
Self-breast examination 322 39 278 37 44 69
Clinical examination 111 14 98 13 3 5 <.0001
Lymph node status
Lymph nodes positive 183 23 156 21 27 42
Lymph nodes negative 473 57 448 59 25 39 .01
Lymph nodes unknown 166 20 154 20 12 19
ER/PR receptor status
ER/PR receptor positive 660 80 619 82 41 64
ER/PR receptor negative 162 20 139 18 23 36 .01
Stage of cancer 17
Stage 0 136 122 16 14 22
Stage I 345 42 331 44 14 22
Stage II 237 29 212 28 25 39
Stage III 57 7 48 6 9 14
Stage IV 21 3 21 3 0 0 <.005
Stage unknown 26 3 24 3 2 3
Treatment
Lumpectomy 651 79 623 76 28 44
Simple mastectomy 16 2 14 2 2 3
MRM 147 18 117 15 33 50
No surgical treatment 8 1 5 0.7 1 1 <.05
in this relatively small cadre, as follows: 5 (1994), 5 (1995),
2 (1996), 3 (1997), 6 (1998), 7 (1999), 6 (2000), 8 (2001), 6
(2002), 6 (2003), and 10 (2004).
When compared with women under 41 years of age, a
higher percentage of women over 40 years of age discovered
their breast cancers by mammography (49%) and had a
higher number of hormone sensitive tumors (87%). The
frequency of lymph node metastases reported in the older
womenwas one-halfthatin theyoungerwomen (21%versus
42%), and a higher percentage of younger women presented
with more advanced disease, a diﬀerence which was statis-
tically signiﬁcant (P<. 05). Many of the patients (in the
unknown lymph node status category) had undergone sim-
ple mastectomy in the 1990s, thus accounting for the overall
20% “unknown” lymph node status, which was 20% in the
>40 year-old and 19% in the <41 year-old group (Table 1).
4.Discussion
Carcinoma of the breast in young women is a relatively
uncommonoccurrence,withourdatadepictinganincidence
of approximately 8% of all women with breast cancer.
This correlates with ﬁndings of other authors who have
reported incidences of 0.3% to 25% [1, 12–14]. Mam-
mography remains the premier screening tool for older
women; however, it is ofquestionable value in young women
primarily because small lesions tend to be undetectable or
interpreted as benign secondary to the increased density of
the breasts of young women, which renders radiographic
diﬀerentiationofnormal from abnormal tissue diﬃcult[15].
Ashley and colleagues found that 77% of mammograms in
young women produced an X-ray suspicious for malignancy,
and only 23% were obviously benign [16]. Ultrasonography
identiﬁed the pathology correctly in 58%, while ﬁne-needle
aspiration (FNA)cytologywas most precise, identifying 78%
of tumors as deﬁnitely malignant and 15% as suspicious,
for an overall accuracy of 93%. The most frequent lesion
noted in this cadre of patients, as well as in other series, is
inﬁltrating duct carcinoma [17].
The prognosis of women with cancer of the breast is
related to a variety of clinical ﬁndings and pathological
factors, especially the status of the axillary lymph nodes and
the tumor size. Studies have also shown that young women
with breast cancer have a lower 5-year relative survival rate
thanolderwomen[12–14,18,19].Ithasbeenpostulatedthat
the tumors in younger women are more aggressive and less
responsive to hormone therapy and that these characteristics
account for the diﬀerencesin 5-year survival between the age
groups [20]( Table 2).
However,it remains unclearwhether thedismal outcome
in the younger age group is a reﬂection of more advanced
disease at the time of diagnosis and/or is due to a diﬀerence
in underlying tumor biology [12, 14, 15, 18]. Finally, it has4 International Journal of Surgical Oncology
Table 2: Five-year survival in breast cancer patients according to
age.
Patient age at diagnosis 5-year survival percentage
Women age 40 years and younger 82%
Women age 41–74 years 89%
Women age 75 years and over 88%
been observed commonly that breast carcinoma appears to
be more indolent generally in older women, and most par-
ticularly in the elderly [21].
5.Conclusion
In 2003, the American Cancer Society recommended that
breast self-examination be optional primarily because of a
lack of unequivocal supporting evidence of beneﬁt. Hence,
the only screening guideline currently suggested for women
18–40 years of age is a clinical breast examination every
three years. However, 5-year survival among young women
diagnosed with breast cancer is clearly related to the stage
of the disease at the time of diagnosis [17, 22]. Thus, early
diagnosis and treatment of breast carcinoma are essential
for optimal prognosis. Breast self-examination has not been
encouraged or recommended, in part, because it has not
been consistently associated with a decrease in morbidity or
mortality, and because it purportedly can cause increased
patient anxiety, especially when biopsies of breast masses
that are discovered on self-examination are performed. We
propose that the anxiety can be dispelled or ameliorated by
quality time spent properly counseling and supporting the
patient.
Our data conﬁrm that young women with breast cancer
arelikelytopresentwithamoreadvanced stageofthedisease
compared with older patients. In response to increasing
breast cancer in young women under 41 years of age
in recent years, further investigation focused on this age
group is indicated, and encouragement of proper breast self-
examination is warranted and should be advocated as a
quality health maintenance practice.
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